An Mpox Multi-Antigen-Tandem Bivalent mRNA Candidate Vaccine Effectively Protects Mice Against the Vaccinia Virus
Background: Since the outbreak of mpox in 2022, the disease has spread rapidly worldwide and garnered significant public attention. Vaccination is regarded as an effective measure to prevent the spread of mpox. The success of the COVID-19 mRNA vaccine demonstrates that mRNA-based vaccines represent...
Saved in:
| Main Authors: | Jun Zuo, Jiayu Wu, Zhen Zhang, Jinrong Long, Changxiao Yu, Yuqin Liao, Hongsheng Zhang, Jing Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/13/4/374 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mpox multi-antigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challenge
by: Jiawei Zeng, et al.
Published: (2023-12-01) -
Vaccinia Virus Vector Bivalent Norovirus Vaccine
by: Yunbo Bai, et al.
Published: (2025-02-01) -
Rational development of multicomponent mRNA vaccine candidates against mpox
by: Rong-Rong Zhang, et al.
Published: (2023-12-01) -
A Single-Chain Mpox mRNA Vaccine Elicits Protective Immune Response in Mice
by: Qian Xu, et al.
Published: (2025-05-01) -
mRNA Vaccine Against Mpox: A Promising Healthcare Strategy
by: Mohammad Shah Alam, et al.
Published: (2025-05-01)